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 10 
A range of well-defined guanidinium-rich linear polymers with demonstrable efficiency for 11 
cellular internalisation were developed. A protected guanidinium-functional acrylamide monomer 12 
(di-Boc-guanidinium ethyl acrylamide, GEAdiBoc) was synthesised and then polymerised via 13 
RAFT polymerisation to yield well-defined homopolymers, which were then deprotected and 14 
functionalised with a fluorescein dye to observe and quantify their cellular uptake. The cellular 15 
uptake of these homopolymers was first compared to polyArginine analogues, which are 16 
commonly used in modern drug delivery. Following this, a range of well-defined guanidinium-17 
 2 
rich copolymers were prepared in which the monomer distribution was varied using a convenient 1 
one-pot sequential RAFT polymerisation approach. Systematic quantification of the cell uptake of 2 
these compounds, supported by fluorescent confocal microscopy data, revealed that while the 3 
overall hydrophobicity of the resulting copolymers has a direct impact on the amount of copolymer 4 
taken up by cells, the distribution of monomers has an influence on both the extent of uptake and 5 
the relative extent to which each route of internalisation (endocytosis vs direct translocation) is 6 
exploited. 7 
 8 
1. INTRODUCTION 9 
The use of polymers as vectors for enhanced drug delivery is now well recognised and continues 10 
to receive enormous interest within the scientific community. Amongst the many advantages that 11 
polymeric systems can offer in pharmaceutical applications, the ability to facilitate the intracellular 12 
trafficking of molecular cargo is one of the most desirable.1 Various aspects of polymeric 13 
architecture have been demonstrated to influence polymer uptake by cells, including primary 14 
microstructure (chain length, tacticity etc.), topology (linear, branched, brush and star polymers) 15 
and self-assembly behavior (vesicles, micelles and worm-like micelles).2, 3 Linear copolymers are 16 
particularly appealing for drug delivery applications since they are synthetically easy to access, 17 
yet benefit from the properties of two or more chemically-distinct monomers in a single polymer 18 
chain, while the overall composition (amount of each monomer type), distribution of monomers 19 
and overall polymer length can be readily varied using controlled polymerisation techniques. Until 20 
recently, these systems were for the most part restricted to either statistically distributed 21 
copolymers, or self-assembled amphiphilic diblock copolymers, while the fundamental influence 22 
 3 
of monomer distribution has remained somewhat under-explored. In recent years, reversible 1 
deactivation radical polymerisation (RDRP) methods such as reversible addition-fragmentation 2 
chain transfer (RAFT) polymerisation and Cu(0)-mediated radical polymerisation have granted 3 
ready access to intermediate levels of monomer distribution in the form of multiblock 4 
copolymers.4-12 With this comes an opportunity to understand the influence of monomer 5 
distribution on biological function on a more fundamental level. We recently studied the effect of 6 
monomer distribution on the uptake of fully hydrophilic copolymers composed of a trio of 7 
biologically-passive acrylamide monomers, dimethylacrylamide (DMA), 4-acryloylmorpholine 8 
(NAM) and N-hydroxyethyl acrylamide (HEA), demonstrating that monomer distribution had 9 
little to no intrinsic impact on cellular uptake when the polymer chains are biologically-inert.13 10 
However, dramatically different conclusions could be expected when at least one monomer with 11 
biological activity is introduced into such systems.  12 
Arginine-rich cell-penetrating peptides such as the Tat peptide and polyArginines have 13 
generated a lot interest in the field of drug delivery due to their proficiency for permeating cellular 14 
membranes. These low molar mass cationic peptides were shown to cross the cell membrane of 15 
mammalian cells mostly via an endocytotic-independent pathway,14 however it should be noted 16 
that they also undergo endocytosis to some extent.15 This behavior is largely attributed to their 17 
guanidinium-rich primary structures rather than the formation of higher-order (i.e. secondary or 18 
tertiary) structure.16 The direct mechanism of cell-entry, while still debated, is thought to proceed 19 
via interaction of the positively charged guanidinium groups with negatively charged lipid 20 
membranes, thus disturbing the membrane structure.17 Various theories, in particular based on the 21 
role of counter-ions, have been suggested as a possible explanation for the enhanced uptake of 22 
Arginine-rich macromolecules compared to those containing other positively charged amino acids 23 
 4 
such as Lysines.18, 19 Nonetheless, the use of the so-called “Arginine-magic” is highly appealing 1 
and as such is frequently exploited to facilitate the intracellular delivery of (macro)molecular 2 
cargo. However, the use of peptides is restrictive in scope in terms of accessible architecture, 3 
limited to low molar mass linear peptides, and moreover solid-phase synthesis can be a time-4 
consuming and expensive process. As a result, polymeric systems similarly rich in guanidinium-5 
moieties have been explored and represent a promising alternative to peptides for enhanced cellular 6 
internalisation. Wender and co-workers have applied this design concept to an extensive variety 7 
of polymeric backbones including poly-peptoids,20 carbamates,21 carbonates,22 and 8 
phosphoesters,23 with demonstrable efficiency for cellular uptake. RDRP techniques have also 9 
been used to prepare well-defined copolymers containing guanidinium pendant groups. 10 
McCormick and co-workers have studied fully hydrophilic guanidinium-rich methacrylamide 11 
copolymers for antimicrobial activity, cell-penetration and cell transfection.24-26 In another 12 
example, Koschek and co-workers used RAFT polymerisation to prepare a small library of 13 
Arginine-containing polymer conjugates and studied the effect of charge and charge distribution 14 
on cellular uptake.27   15 
Among the various factors which can affect the cellular uptake of polymers, hydrophobicity has 16 
been found to play a particularly important role. Increasing the overall hydrophobicity of 17 
polymeric systems is an effective approach towards promoting interaction between the cationic 18 
polymer chains and cellular membranes.28 The nature of the polymer backbone can strongly 19 
influence the overall hydrophobicity of the polymer chains, and thus their cellular interaction. For 20 
example, Tew and co-workers investigated the delivery of siRNA or proteins using guanidinium-21 
rich polymers with different backbone composition (methacrylate, styrenic and noroborene), and 22 
observed that polymers possessing increased hydrophobicity resulted in enhanced intracellular 23 
 5 
delivery, although it was stressed that the type and amount hydrophobicity is a crucial factor.29 An 1 
altogether simpler approach towards tuning hydrophobicity entails incorporating both cationic and 2 
hydrophobic monomers through copolymerisation to generate amphiphilic polymer chains. 3 
Indeed, several studies have shown that increasing the overall hydrophobicity of cationic polymers 4 
through copolymerisation may lead to enhanced cellular uptake.29-35 However, despite the 5 
widespread use of these systems, the fundamental influence of monomer distribution on the 6 
cellular uptake of cationic copolymer systems has received little attention, since previous studies 7 
focus on amphiphilic copolymers that tend to self-assemble or fold in aqueous solution.34, 36 This 8 
is especially true for fully-soluble guanidinium-rich polymers, for which the effect of monomer 9 
distribution on cellular internalisation remains unexplored. 10 
In this work, we investigate the influence of monomer distribution on the cellular uptake of fully 11 
soluble copolymers containing a mixture of guanidinium-functional monomer and less hydrophilic 12 
neutral monomers. Well-defined guanidinium-rich homopolymers and copolymers were prepared 13 
via RAFT polymerisation. Firstly, low molar mass poly(guanidine ethyl acrylamide) (pGEA) 14 
homopolymers with narrow molar mass distribution (Đ) were compared to monodisperse 15 
polyArginine analogues possessing an equivalent number of arginine residues to determine the 16 
extent and the mechanism by which the polymers enter cells. Following this, we prepared a range 17 
of low molar mass (less than 6000 g.mol-1) copolymers each containing a 50 % molar ratio of 18 
guanidinium-functional GEA monomer with one of two biologically passive (and less hydrophilic) 19 
comonomers, varying the block structure (statistical, tetrablock and diblock) to investigate the 20 
impact of co-monomer type and monomer distribution on their cellular uptake.  21 
 22 
2. MATERIALS AND METHODS 23 
 6 
2.1 Materials. 5-FITC cadaverine was obtained from AAT Bioquest and used as received. 5-1 
((5-aminopentyl)thioureidyl)fluorescein, trifluoroacetate salt (fluorescein cadaverine) was 2 
obtained  from Biotium and used as received. Trifluoroacetic acid (TFA, 99 %) was obtained from 3 
Acros Organics and used as received. 1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP), 4-4 
methylmorpholine (NMM) (99 %) and Triisopropylsilane (TIPS) (98 %) were obtained from Alfa 5 
Aesar and used as received. 1,3-Bis(tert-butoxycarbonyl)-2-methyl-2-thiopseudourea (98 %), 6 
ethylenediamine, was obtained from Aldrich and N-Ethyldiisopropylamine (DIPEA) was obtained 7 
from Fluka and used as received. O-(1H-6-Chlorobenzotriazole-1-yl)-1,1,3,3-tetramethyluronium 8 
hexafluorophosphate (HCTU), 2-Chlorotrityl chloride resin and Fmoc-protected amino acids were 9 
purchased from Iris Biotech. And used as received. N,N-dimethylacrylamide (DMA, 99 %) and N-10 
hydroxyethyl acrylamide (HEA, 97 %) were obtained from Sigma Aldrich and passed through 11 
basic alumina to remove inhibitor. DMF, ethyl acetate, hexane, methanol, ethanol, acryloyl 12 
chloride, 1,4-dioxane was obtained from Fisher Scientific and used as received. 2,2′-Azobis[2-(2-13 
imidazolin-2-yl)propane] dihydrochloride (VA-044) was obtained from Wako and used as 14 
received. The chain transfer agent 2-(((butylthio)-carbonothioyl)thio)propanoic acid (called 15 
(propanoic acid)yl butyl trithiocarbonate, PABTC in this work),was prepared according to a 16 
previously reported procedure.37  17 
2.2. Synthesis and characterisation of compounds. Synthesis of polyArginine and fluorescein-18 
polyArginine, synthesis of 1,3-Di-Boc-guanidinoethyl acrylamide (GEAdiBoc) monomer, monomer 19 
characterisation via NMR and Mass Spectrometry, homopolymerisation, block copolymerisation, 20 
deprotection of polymers and attachment of fluorescein cadaverine are described in Supporting 21 
Information. 22 
 7 
2.3. Size exclusion chromatography (SEC). SEC was conducted using an Agilent 390-LC 1 
MDS instrument equipped with differential refractive index (DRI), viscometry (VS), dual angle 2 
light scattering (LS) and dual wavelength UV detectors. The liquid chromatography system used 3 
2 x PLgel Mixed D columns (300 x 7.5 mm) and a PLgel 5 μm guard column. The 4 
dimethlyformamide (DMF) eluent contained 5 mmol NH4BF4 as additive. Samples were run at 1 5 
ml.min-1 at 50 °C. Analyte samples were filtered through a polytetrafluoroethylene (PTFE) 6 
membrane with 0.2 μm pore size prior to injection. Poly(methyl methacrylate) (PMMA) narrow 7 
standards (Agilent EasyVials) were used to calibrate the SEC system. Experimental Mn,SEC and Đ 8 
(Mw / Mn) of synthesised polymers were determined using Agilent GPC software. 9 
2.4. Nuclear magnetic resonance spectroscopy (NMR). 1H NMR spectra were recorded on a 10 
Bruker Avance III HD 300 MHz, Bruker Avance III HD 400 MHz or Bruker Avance III HD 500 11 
MHz spectrometer at 298 K. The theoretical number-average molar mass (Mn,th) of the RAFT 12 
polymers was calculated using the following equation:             13 
                                   14 
Where [M]0 and [CTA]0 are the initial concentrations (in mol.L
-1) of monomer and chain transfer 15 
agent respectively; p is the monomer conversion (as determined by 1H NMR); MM and MCTA are 16 
the molar masses (g.mol-1) of the monomer and CTA respectively. 17 
2.5. Analytical high performance liquid chromatography (HPLC). HPLC analysis was done 18 
on an Agilent 1260 Infinity series stack equipped with an Agilent 1260 variable wavelength 19 
detector and an Agilent 1260 fluorescence detector. The HPLC was fitted with a Phenomenex 20 
Luna® C18 (250 × 4.6 mm) column with 5 μm micron packing (100 Å). Mobile phase A consisted 21 
of water containing 0.05 % TFA, mobile Phase B consisted of acetonitrile containing 0.05 % TFA. 22 
The gradient used for HPLC analysis increased from 5 % to 95 % B over 40 minutes. Detection 23 
𝑀n,th =
[M]0𝑝𝑀M
[CTA]0
+  𝑀CTA 
 8 
was achieved via monitoring at 309 nm for the polymers (trithiocarbonate group) and 220 nm for 1 
the peptides (amide bond). Fluorescent detection was monitored using 𝜆ex = 490 nm and 𝜆em = 2 
525 nm.  3 
2.6. Dynamic light scattering (DLS). Size measurements were conducted on a Malvern 4 
Zetasizer Nano-ZS at 25 °C with a 4 mW He-Ne 633 nm laser at a scattering angle of 173 ° (back 5 
scattering), assuming the refractive of PMMA. The measurements were repeated three times with 6 
automatic attenuation selection and measurement position. Results were analyzed using Malvern 7 
DTS 6.20 software. 8 
2.7 Maldi-TOF. Samples for Maldi-TOF measurements were mixed at 1 mg.mL-1 into 50:50 9 
deionised water/THF with 0.1 mg.ml-1 NaI and 0.1 mol.L-1 chloroacetic acid, 15 mg.mL-1 of Super 10 
Dihydroxybenzoic acid (SDHB). 0.5 µL of the solution was then deposited onto an MTP384 11 
ground steel target plate and analyzed using a Bruker UltrafleXtreme Maldi TOF/TOF analyzer. 12 
The samples were analyzed in a reflectron positive mode with a 21 kV reflecting voltage and an 13 
18 kV detection voltage, using a 355 nm laser set to 26 % laser power. 14 
2.8. Cell lines and cell culture. MDA-MB-231 cells were cultivated in Dulbecco’s modified 15 
eagle medium (DMEM) supplemented with 10 % fetal bovine serum and 2 mM L-glutamine. 16 
Caco2 cells were cultivated in 1:1 DMEM:F12 medium supplemented with 10 % fetal bovine 17 
serum and 2 mM L-glutamine. 18 
2.9. Cytotoxicity assays. Cell viability was tested using a standard protocol for the XTT assay.38 19 
Briefly, Caco2 cells were seeded in 96 well plates at a density of 1 × 104 cells per well and allowed 20 
to attach for 24 h. The culture medium was replaced with fresh medium containing a series of 21 
dilutions of polymers or peptides (100, 50, 10, 1 and 0.1 μmol.L-1). Following 24 h incubation, the 22 
medium was replaced with fresh medium and 25 uL of a solution of XTT (1 mg.mL-1) containing 23 
 9 
N-methyl dibenzopyrazine methyl sulfate (PMS) (25 μmol.L-1) in medium was added. Cells were 1 
further incubated for 16 h. Absorbance of samples were then measured using a Synergy HTX plate 2 
reader at 450 nm and 650 nm (background). 3 
 2.10. Confocal microscopy. MDA-MB-231 cells were chosen for confocal imaging as they are 4 
easier to image than Caco2 which grow as aggregates. Briefly, MDA-MB-231 cells were seeded 5 
in an 8-well ibidi plate at a density of 1 × 104 cells per well and allowed to grow for 24 hours prior 6 
to the experiment. The culture medium was replaced with fresh media containing the compounds 7 
at either 5 μmol.L-1 (R20, pGEA20) or 2 μmol.L-1 (DMAstat, DMAdiblock) previously prepared from 8 
stock solutions in pure water at 500 µmol.L-1. For incubation at 4 °C, cells were cooled down 30 9 
minutes prior to incubation with the compounds. Cells were then left to incubate for either 2 h or 10 
16 h at the indicated temperature. Lysotracker RedTM was added to the appropriate well 2 h prior 11 
to the end of incubation following supplier recommendations. Hoescht 33342 was added to all the 12 
wells 15 minutes prior to the end of the incubation to stain the nucleus of the cells. Following 13 
incubation, cells were washed with warm medium twice, and fresh medium was added. Confocal 14 
microscopy images were taken on a Leica TCS SP5 (Carl Zeiss, Germany) at a temperature of 15 
either 37 °C or at room temperature (for 4 °C experiments), using sequential scanning for each 16 
channel.  Excitation/Emission used for measurement are used as follow: nucleus channel (405 / 17 
410-458 nm), fluorescein channel (488 / 511-564 nm), Lysotracker RedTM (561 / 589 - 708nm).  18 
2.11. Cellular uptake experiments. Cellular uptake was quantified via measurement of the 19 
intracellular fluorescence following incubation with fluorescein-labelled polymers or peptide. 20 
Briefly, MDA-MB-231 cells or Caco2 cells were seeded into a black 96 well plate with a clear 21 
bottom, at a density of 5000 cells per well, and were allowed to grow for 24 h. The culture medium 22 
was replaced with fresh media containing the compounds at either 5 μmol.L-1 (R9, R20, pGEA9, 23 
 10 
pGEA20, pGEA40) or 2 μmol.L-1 (pGEA40, pDMA40, pHEAm40, copolymers) previously prepared 1 
from stock solutions in pure water at 500 µmol.L-1. For incubation at 4 °C, cells were cooled down 2 
30 minutes prior to incubation with the compounds. Cells were then left to incubate for either 2 h 3 
or 16 h at the indicated temperature. Hoescht 33342 was added to all the wells 15 minutes prior to 4 
the end of the incubation to stain the nucleus of the cells. Following incubation, cells were washed 5 
with medium twice, and fresh medium was added. Each well was then imaged individually using 6 
a Cytation3 Cell Imaging Multi-Mode ReaderTM from Biotek®. Using Gen5TM software, single 7 
cells were isolated using the blue channel corresponding to Hoescht 33342. An area extending the 8 
nucleus area of the cells by 7 µM or 20 µM for MDA-MB-231 or Caco2 cells, respectively, was 9 
arbitrarily defined as the cell area. Following background reduction using a rolling ball model (30 10 
µM), intracellular fluorescence in individual cells was quantified using the fluorescence associated 11 
with fluorescein (GFP filter, λex = 469 nm, λem = 525 nm) in the area of each cell. The average 12 
mean of fluorescence in each well was then used as the sample value. The data given are 13 
representative of two separate experiments where each sample was measured in triplicate (n = 4). 14 
All errors reported correspond to the standard deviation from the mean.  15 
 16 
3. RESULTS AND DISCUSSION 17 
3.1. Monomer Synthesis. The polymers synthesised in this work were all comprised of 18 
acrylamide monomers. Due to their high kp and kp/(kt)
1/2
, acrylamide monomers may typically be 19 
polymerised to quantitative monomer conversion using only very low initiator concentrations, 20 
thereby preserving a high fraction of living ω-chain ends. With such a system, multiple chain-21 
extensions may be conducted to generate (in one-pot) well-defined (multi)block copolymers.5-7, 9 22 
Acrylamides are also advantageous in that they are generally not prone to side reactions of transfer 23 
 11 
during polymerisation and are stable towards hydrolysis. Hence, we designed an acrylamide 1 
monomer bearing a pendant (Boc-protected) guanidine moiety, whose resulting polymers, once 2 
deprotected, would yield polymeric chains with pendant guanidinium moieties similar to 3 
polyArginine. The di-Boc-protected guanidine ethyl acrylamide (GEAdiBoc) was prepared in a two-4 
step synthesis as shown in Scheme 1. Since the beginning of this work, this monomer synthesis 5 
has been reported, albeit as an intermediate which was not purified or characterised.39 6 
 7 
 8 
Scheme 1. Synthesis of GEAdiBoc (a); i) DCM, 3 h. ii) TEA, DCM, < 10 °C, 16 h. Synthesis of 9 
pGEAdiBoc via RAFT polymerisation (b); iii) VA-044, 1,4-dioxane/H2O, 45 °C, 7 h. iv) 10 
Deprotection of pGEAdiBoc; iv) TFA/TIPS/H2O, RT, 3 h. Structure of polyArginine (c). 11 
 12 
3.2. Synthesis of guanidinium-rich homopolymers via RAFT polymerisation. Having 13 
designed and synthesised the protected guanidinium-functional acrylamide monomer, we initially 14 
n = 9/20 n = 9/20
i)
ii)
iii)
iv)
a)
c)
b)
vs
 12 
wanted to compare the proficiency of well-defined low molar mass poly(guanidine ethyl 1 
acrylamide) (pGEA) homopolymers for cellular internalisation with the commonly-used 2 
monodisperse polyArginine analogues prepared via solid phase peptide synthesis (SPPS). The 3 
principal difference between these classes of guanidinium-rich compounds are their polymeric 4 
backbones, with the vinyl backbone of the RAFT polymers expected to be more hydrophobic than 5 
their peptidic equivalents (Scheme 1). SPPS by nature enables near-perfect control over monomer 6 
sequence and the length of peptide chains (up to a certain number of residues), which is beyond 7 
the scope of RDRP. However, considering this part of the study concerns homopolymers, polymers 8 
with equivalent DPn and narrow molar mass distributions (Đ), as may be obtained using RDRP, 9 
are still expected to provide a valid comparison. The GEA monomer was polymerised in its 10 
protected form (GEAdiBoc) using (propanoic acid)yl butyl trithiocarbonate (PABTC) as chain 11 
transfer agent (CTA). This CTA was selected since it affords control over the polymerisation of 12 
acrylamide monomers, while the COOH of the R-group may be readily exploited to functionalise 13 
the α-chain end of the resulting polymers. RAFT polymerisations were conducted at 45 °C using 14 
1,4-dioxane/water as a solvent system and 2,2′-Azobis[2-(2-imidazolin-2-yl)propane] 15 
dihydrochloride (VA-044) as the initiator. Well-defined pGEAdiBoc homopolymers were prepared 16 
with a DPn of 9 (pGEA9) or 20 (pGEA20) as determined by 
1H NMR (shown for pGEA9 in Fig. 17 
S2), with DMF-SEC revealing monomodal populations with narrow molar mass distributions (Đ 18 
= 1.1) (Table 1 and Fig. S2). Further details on polymerisation conditions and synthesis of the two 19 
peptide controls (R9 and R20) are provided in the Supporting Information. 20 
 21 
 22 
 23 
 24 
 13 
Table 1. Summary of homo- and copolymers prepared via RAFT polymerisation. 1 
Compound Composition 
Mn,th
a
 
(g.mol-1) 
Mn,expt
b
                
(g.mol-1) 
Đexptb 
pGEA9 pGEA9 1650
c (3450) 3100 1.12 
pGEA20 pGEA20 3400
c  (7350) 5600 1.10 
pGEA40 pGEA40 6600
c  (14500) 9750 1.14 
DMAstat pDMA20-st-pGEA20 
5400c  (9350) 
8600 1.10 
DMAtetra pDMA10-b-pGEA10-b-pDMA10-b-pGEA10 9400 1.08 
DMAdiblock pDMA20-b-pGEA20 8050 1.11 
HEAstat pHEA20-st-pGEA20 
5700c  (9650) 
9200 1.12 
HEAtetra pHEA10-b-pGEA10-b-pHEA10-b-pGEA10 9950 1.17 
HEAdiblock pHEA20-b-pGEA20 9700 1.13 
a Determined using equation 1 (experimental part). 
b Determined using DMF-SEC with PMMA narrow standards, polymers are in their Boc-
protected form. 
c Theoretical molar mass of polymers following deprotection. 
 2 
The experimental molar masses (Mn,expt) obtained  for both pGEA9 and pGEA20, in their 3 
protected form, are slightly below the theoretically calculated values (Table 1), which may be 4 
attributed to a difference in hydrodynamic volume between pGEAdiBoc and the PMMA narrow 5 
standards used to calibrate the SEC system. Deprotection of the pGEAdiBoc homopolymers to yield 6 
well-defined pGEA with cationic guanidinium pendant groups was achieved using trifluoroacetic 7 
acid (TFA) in the presence of scavengers. Successful removal of the Boc protecting groups to yield 8 
the desired guanidinium-pendant groups was confirmed using 1H NMR, as exemplified using 9 
pGEA9 in Fig. S2.  10 
 14 
For cell uptake studies, the compounds were functionalised with a fluorescein derivative. 1 
Peptides R9 and R20 were modified with fluorescein-NHS at their N-terminus directly on the resin 2 
and the excess dye washed off before proceeding to the cleavage step. Fluorescein cadaverine was 3 
introduced to the α-chain end of pGEA9 and pGEA20 via HCTU coupling in DMF. Removal of 4 
excess free dye was achieved via extensive dialysis and was quantified using HPLC until less than 5 
10 % of free dye remained. Fluorescent HPLC traces of the final compounds are presented in Fig. 6 
S3. In the case of pGEA9 and pGEA20 two peaks were observed, however HPLC conducted prior 7 
to dye attachment revealed only a single peak (Fig. S4). Matrix assisted laser 8 
desorption/ionisation-time of flight mass spectrometry (Maldi-TOF-MS) analysis of pGEA9 (Fig. 9 
S5) suggests the presence of two side reactions, namely removal of the trithiocarbonate end of the 10 
polymer and partial hydrolysis of the thioamide bond of fluorescein cadaverine. These side 11 
reactions may occur either during the measurement as part of the fractionation process, or during 12 
the dialysis step, which may account for the two peaks observed in HPLC. To account for any 13 
differences in the fluorescence intensity for each compound, a fluorescence correction factor was 14 
calculated from the slope of their respective fluorescence profiles (Table S4).13 To ensure that the 15 
presence of hydrolysed dye does not affect uptake studies, control samples in which fluorescein 16 
cadaverine was incubated in the presence of cells for 16 h were carried out, which revealed no 17 
intracellular fluorescence at the concentrations used elsewhere in this study (Table S4).  18 
 19 
3.3. Comparison of pGEA homopolymers and polyArginines. Acute toxicity of the 20 
polyArginines (R9 and R20) and guanidinium-rich pGEA RAFT homopolymers (pGEA9 and 21 
pGEA20) was assessed using colorectal adenocarcinoma Caco2 cells. Peptides R9 and R20 were 22 
found to be non-toxic at concentrations up to 100 µM following 24 h incubation (Fig. S6), which 23 
 15 
is consistent with previous observations in the literature.40 In contrast, incubation with the 1 
analogous RAFT polymers pGEA9 and pGEA20 resulted in decreased cell viability at 2 
concentrations above 50 µM and 10 µM, respectively. To assess whether the comparably higher 3 
toxicity of the RAFT polymers could be due to enhanced uptake of the compounds, we proceeded 4 
to study their intracellular uptake. With delivery of anticancer drugs in focus, this was conducted 5 
on both colorectal adenocarcinoma Caco2 cells and human breast adenocarcinoma MDA-MB-231 6 
cells, two well-established model cancer cell lines.  7 
MDA-MB-231 and Caco2 cells were incubated with non-toxic concentrations of the fluorescent 8 
compounds (5 µM) for 2 or 16 h, and uptake was quantified by measuring the intracellular 9 
fluorescence (Fig. 1 and S7). Levels of intracellular uptake measured in MDA for pGEA RAFT 10 
polymers were found to be higher in comparison to their polyArginines analogues of similar length 11 
(at both 2 and 16 h of incubation). This observation may be attributed to greater hydrophobicity of 12 
the vinyl backbone of pGEA relative to the amide backbone of polyArginines, as demonstrated by 13 
the later retention times observed in HPLC for the polymers (Fig. S3). This explanation is in 14 
accordance with a recent study on the delivery of green fluorescent protein by guanidinium-based 15 
polymers with various backbone chemistry, which found that an increase in the overall 16 
hydrophobicity of cell-penetrating systems typically lead to enhanced cellular uptake.29 At 17 
equimolar concentrations, the higher molar mass compounds (R20 and pGEA20) are internalised 18 
more than their respective lower molar mass equivalents, likely due to the increased number of 19 
guanidinium residues in solution. Mitchell and co-workers demonstrated than the uptake of 20 
polyArginine peptides by Jurkat cells after 5 min of incubation increased as a function of peptide 21 
length up to 15 residues, after which it starts to decrease.41 The same study showed a linear increase 22 
in intracellular uptake as a function of time for a polyArginine (R7), which was also observed for 23 
 16 
pGEA9 and pGEA20 in the present study. In contrast, the intracellular uptake of R9 or R20 was found 1 
to be relatively time-independent, except in MDA cells where the intracellular fluorescence 2 
following 2 h incubation with R9 was found to be reproducibly greater than after 16 h. Futaki and 3 
co-workers reported a loss of intracellular fluorescence associated with the Arginine-rich CPP 4 
HIV-1 Rev(34-50) over time, which they attributed to intracellular degradation of the peptide 5 
rather than leakage from the cells.42 The fact that this is only observed for the low molar mass 6 
polyArginine (R9) in our case may indicate that the mechanism of cellular uptake for this 7 
compound may differ from the other compounds studied.  8 
 9 
 10 
 11 
Figure 1. Comparison of the cell uptake of polyArginine peptides vs RAFT polymer equivalents. 12 
Fluorescence intensity measured in MDA-MB-231 cells incubated with 5 µM of R9, pGEA9, R20 13 
and pGEA20 for the indicated time and temperature.  14 
 15 
 To further explore the mechanism of uptake, the ability of the compounds to enter cells via non-16 
endocytotic pathways (i.e. passive membrane translocation) was quantified by incubating the 17 
samples at 4 °C (Fig. 1 and S7 for MDA-MB-231 and Caco2 cells, respectively). As expected, the 18 
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extent of cellular uptake in MDA-231-MB cells at 4 °C was relatively similar to that observed at 1 
37 °C (after 2 h incubation) for all four compounds, which is consistent with other reports that 2 
guanidinium-rich macromolecules are mostly internalised via passive crossing.43 Similar results 3 
were observed in Caco2, with the exception of pGEA20 which is not conclusive. The intracellular 4 
uptake of R20 and pGEA20 by MDA-MB-231 cells was further studied using confocal microscopy 5 
(Fig. 2). Incubation with either compound at 37 °C, for 2 h or 16 h, revealed patterns of punctate 6 
fluorescent within the cells, characteristic of vesicular uptake. Furthermore, co-localisation of 7 
these puncta with LysotrackerTM Red indicate that the majority of the internalised R20 and pGEA20 8 
were located in lysosomal compartments of cells after 2 h or more. When incubation was 9 
conducted at 4 °C (2 h), an altogether different distribution of intracellular fluorescence was 10 
observed, with fluorescence instead found diffused throughout the cell (Fig. 2). In the case of R20, 11 
cells were observed to be entirely fluorescent, including the nucleus. Similar observations were 12 
made by Fretz and co-workers in a thorough study of the influence of temperature on the cell 13 
uptake of L-octaarginine.43 With pGEA20 the dispersion of fluorescence across each cell is less 14 
profound, and indeed does not cross into the nucleus area of the cells, possibly due to a weaker 15 
membrane permeation potential (Fig. 2). 16 
Taken together, these results suggest a relatively similar mechanism of uptake for both pGEA20 17 
and R20 with passive permeation through the cell membranes being the main uptake pathway. Yet, 18 
a smaller amount of compound is taken up via endocytosis at 37 °C, resulting in concentrated 19 
pockets of fluorescent compound in the endosomes and lysosomes, arising in the bright puncta 20 
observed in the microscopy images.  21 
 22 
 18 
 1 
Lysotracker
Compound
(fluorescein
-labelled) Overlay
Merge 
(Brightfield + 
Hoescht 33342)
R
2
0
2
 h
, 
4
 ᵒ
C
p
G
E
A
2
0
2
 h
, 
4
 ᵒ
C
R
2
0
2
 h
, 
3
7
 ᵒ
C
p
G
E
A
2
0
2
 h
, 
3
7
 ᵒ
C
R
2
0
1
6
 h
, 
3
7
 ᵒ
C
p
G
E
A
2
0
1
6
 h
, 
3
7
 ᵒ
C
 19 
Figure 2. Confocal microscopic images of the intracellular location of R20 and pGEA20 in live 1 
MDA-MB-231 cells following incubation at the indicated time and temperature Cells were stained 2 
with Lysotracker™ Red and Hoechst 33342 to stain the lysosomes and nucleus, respectively. Co-3 
localisation of the compounds with the lysosomes resulted in yellow spots in the overlay images. 4 
 5 
3.4. Synthesis of guanidine-rich copolymers via RAFT polymerisation. Having established 6 
the propensity of the acrylamide-based pGEA RAFT polymers for cellular uptake, we proceeded 7 
to introduce hydrophobic comonomers into the system, investigating both the influence of 8 
comonomer and their distribution along the polymer backbone on cellular uptake. Two acrylamide 9 
monomers, N,N-dimethylacrylamide (DMA) and N-hydroxyethyl acrylamide (HEA) were selected 10 
for this study. These monomers are uncharged and, to the best of our knowledge, biologically inert. 11 
Their corresponding polymers are both more hydrophobic than pGEA, as indicated by HPLC 12 
traces of their respective homopolymers (Fig. S15), yet sufficiently hydrophilic to ensure the 13 
resulting copolymers do not self-assemble or aggregate in solution, allowing this study to 14 
investigate the fundamental influence of polymer microstructure on intracellular uptake. 15 
A series of relatively low molar mass (< 6000 g.mol-1) copolymers with an overall composition 16 
of 20 units of “active” GEA monomer and 20 units of “inactive” comonomer (DMA or HEA) were 17 
targeted, comprised of either one, two or four distinct blocks (statistical, diblock and tetrablock 18 
copolymer, respectively). These copolymers were prepared via RAFT polymerisation using 19 
conditions similar to those described above. A breakdown of all polymer synthesis is provided in 20 
the Supporting Information (Table S1 and S2). Statistical copolymers DMAstat and HEAstat were 21 
prepared in a single polymerisation step conducted in dioxane/H2O (80/20 v/v) at 45 °C. Near-22 
quantitative monomer conversion was achieved within 5 h in each case and DMF-SEC indicated 23 
 20 
the successful preparation of well-defined copolymer, exhibiting a monomodal population with 1 
only a small amount of low molar mass tailing (Fig. 3, S8 and S9). The compositional drift of 2 
these statistical copolymers was assessed by following the polymerisation kinetics, where it was 3 
determined that each monomer is incorporated at a similar rate, indicating an equal distribution of 4 
each monomer along the polymer backbone (Fig. S10 and S11). Meanwhile the diblock 5 
copolymers (DMAdiblock and HEAdiblock) and tetrablock copolymers (DMAtetra and HEAtetra) were 6 
prepared via a one-pot sequential polymerisation approach (Scheme 2). In each case, the “inactive” 7 
monomer (DMA or HEA) was polymerised as the initial block under highly optimised conditions 8 
(high monomer concentration, water content and temperature) to achieve quantitative monomer 9 
conversion after only 2 h, with a high [PABTC]0/[VA-044]0 ratio (60 or more) and consequently 10 
a (theoretical) high fraction of living chains. For the synthesis of the subsequent block(s), in order 11 
to successfully incorporate the GEAdiBoc monomer, polymerisations were conducted at 45 °C (20 12 
h per block) with substantially decreased monomer concentrations and an increased dioxane 13 
content (≈ 80 % of solvent composition). Nevertheless, relatively high [PABTC]0/[VA-044]0 ratios 14 
(the lowest for any block synthesis was ≈ 20) could be employed in all cases (Table S2). Near-15 
quantitative monomer conversions (> 95 %) were achieved in all cases while DMF-SEC revealed 16 
a clear shift towards higher molar mass with each successive chain extension (Fig. S8 and S9), 17 
with the final purified polymers possessing narrow molar mass distributions (Đ < 1.2) (Table 1 18 
and S3). 19 
The molar masses determined from DMF-SEC for each copolymer microstructure (statistical, 20 
tetrablock and diblock) were in relatively close agreement and indeed the chromatograms are 21 
found to overlap well (Fig. S8 and S9). The polymers were deprotected using TFA as with the 22 
pGEA homopolymers, with 1H NMR confirming removal of the Boc protecting groups (shown for 23 
 21 
both DMAstat and HEAstat in Fig. S12 and S13). Dynamic light scattering (DLS) measurements 1 
conducted on the copolymer compounds confirm the absence of self-assembly behavior at a 2 
concentration of 100 mM in PBS, which is far higher than those used in this study (Fig. S19).  3 
  4 
Scheme 2. Synthesis of pDMA10-b-pGEA10-b-pDMA10-b-pGEA10 tetrablock copolymer prepared 5 
via one-pot sequential addition RAFT polymerisation.  6 
 7 
3.5. Influence of comonomer on cell uptake. Acute toxicity profiles for these six guanidinium-8 
rich copolymers, as well as homopolymers of each monomer (pGEA40, pHEA40 and pDMA40, 9 
Table S3 and Fig. S14) against Caco2 cells are shown in Fig. S16. Following the trend observed 10 
for pGEA9 and pGEA20, the higher molar mass pGEA40 was found to be toxic at concentrations as 11 
low as 10 µM. In contrast, pHEA40 and pDMA40 did not appear to affect cell viability within the 12 
concentration range studied. The copolymers, each comprising on average 20 units of the cationic 13 
GEA monomer, exhibited toxicity comparable to that of pGEA20. No clear trend was observed 14 
between toxicity and copolymer microstructure, with most compounds showing some toxicity at 15 
VA-044
Dioxane/H2O
45  C, 20 h
VA-044
Dioxane/H2O
70  C, 2 h
TFA:TIPS:H2O
RT, 3 h
VA-044
Dioxane/H2O
45  C, 20 h
(x 2)Dimethylacrylamide
(DMA)
di-Boc-guanidine ethylacrylamide
(GEAdiBOC)
 22 
concentrations above 10 µM, suggesting that copolymerisation of GEA with DMA and HEA does 1 
not inherently reduce toxicity. 2 
Next, the polymers were labelled with a fluorescein cadaverine dye (Fluorescent HPLC shown 3 
in Fig. S15, corrected fluorescence shown in Table S4) and their uptake by MDA-MB-231 and 4 
Caco2 cell lines quantified (Fig. 3, S17 and S18). As with pGEA9 and pGEA20, uptake of the 5 
copolymers was found to be dependent on incubation time at 37 °C, with cellular fluorescence 6 
generally increasing with longer incubation times (2 to 16 h). Interestingly, both DMAstat and 7 
HEAstat were taken up by cells more than pGEA40, despite possessing half as many guanidinium 8 
moieties (on average) per polymer chain. We attribute this to an increase in the overall 9 
hydrophobicity of the polymers from the incorporation of the more hydrophobic comonomers. 10 
This is further supported by the observation that, in both of the cell lines studied, DMAstat was 11 
internalised more than its less hydrophobic HEA-containing equivalent (HEAstat), as indicated by 12 
the HPLC chromatograms of the final compounds (Fig. S15). This is consistent with reported 13 
literature that the overall hydrophobicity of (soluble) copolymer systems has an influence their 14 
cellular uptake behaviour.28, 44 However, the more segmented copolymer microstructures 15 
(tetrablock and diblock copolymers) of DMA and HEA were not internalised more than pGEA40, 16 
suggesting that the monomer distribution also has a strong influence on the extent, and possibly 17 
also the mechanism, of intracellular uptake.  18 
 19 
 23 
 1 
Figure 3. Comparison of the cell uptake of RAFT guanidinium-rich copolymers with various 2 
architecture (DP = 40). Fluorescence intensity measured in MDA-MB-231 cells incubated with 2 3 
µM of DMAstat, HEAstat, DMAtetra, HEAtetra, DMAdiblock and HEAdiblock for the indicated time and 4 
temperature. 5 
 6 
3.6. Influence of copolymer segmentation. Next, we proceeded to explore the impact of 7 
segregating the two distinct chemical functionalities. Results are reported in Fig. 3 for MDA-MB-8 
231 cells and Fig. S17 for Caco2 cells. In both copolymer systems, increasing the segregation of 9 
comonomers from statistical to tetrablock to diblock copolymer resulted in a significant decrease 10 
in the extent of internalisation. With exception of DMAstat, HPLC indicates that the hydrophilicity 11 
of the copolymers remain relatively similar regardless of microstructure, suggesting that 12 
differences in hydrophobicity cannot solely account for the differences in the extent of cell uptake 13 
observed (Fig. S15). Only considering hydrophobicity would fail to explain, for example, why 14 
HEAstat is internalised more efficiently than DMAdiblock, since the latter is still expected to be more 15 
hydrophobic. Rather, the distribution of the cationic and hydrophobic moieties along the polymer 16 
backbone should be considered. Barz and co-workers reported that statistical copolymers 17 
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 24 
comprised of N-(2-hydroxypropyl)methacrylamide (HPMA) and lauryl methacrylate (LMA), 1 
which were shown to forms aggregates, entered cancer cells more efficiently than their micelle-2 
forming block copolymer counterparts.45 However, this should not be the case in our copolymer 3 
systems since they are fully hydrophilic, and indeed DLS does not indicate the occurrence of self-4 
assembly for any compounds (Fig. S19). One possible explanation is the more even distribution 5 
of guanidinium groups in the statistical copolymers compared to the block copolymer equivalents. 6 
Condensing the guanidinium moieties into defined blocks on an already compact vinyl backbone 7 
could be expected to decrease the number of surface charge available, thus restricting electrostatic 8 
interaction with the negatively charged lipid membrane of cells, which may explain our 9 
observations. Rothbard and co-workers reported that the introduction of non-arginine spacer 10 
residues in polyArginine decamers could lead to improved uptake by Jurkat cells.46 Indeed, they 11 
showed that decamers containing three non-arginine spacer residues were internalised more than 12 
a heptaArginine (R7) itself.  13 
In an attempt to understand this effect better, the cellular uptake was also measured at 4 °C. In 14 
contrast with the pGEA homopolymers, the copolymers generally experienced reduced 15 
internalisation in MDA-231-MB cells when incubated at 4 °C (Table S5). Similar results were 16 
observed in Caco2 cells, except in the case of DMAtetra which is inconclusive. These results suggest 17 
that the uptake of these guanidinium-rich copolymers occurs, regardless of the microstructure, via 18 
a combination of both membrane permeation and endocytic uptake. We then studied the 19 
internalisation of DMAstat and DMAdiblock by MDA-MB-231 cells via confocal microscopy to 20 
assess whether the monomer distribution had any effect on the cell uptake pathway (Fig. 4). At 37 21 
°C, incubation for 2 h with either compound lead to the observation of punctate patterns of 22 
fluorescence, indicative of uptake via endocytosis. These were not colocalised with LysotrackerTM 23 
 25 
Red suggesting that the fluorescent compounds had not yet accumulated in the lysosomes after 2 1 
h. However, following 16 h of incubation these puncta were found to mostly colocalise with the 2 
lysosomes, confirming that a significant proportion of the compounds were internalised via 3 
endocytosis. However, in the case of DMAdiblock, some of the fluorescence observed in cells 4 
incubated (following 2 or 16 h incubation at 37 °C) was found to be dispersed throughout the 5 
cytosol, which would indicate that a considerable amount of this compound was also taken up via 6 
a non-endocytotic pathway. This suggests that a greater proportion of the diblock copolymer 7 
crosses the membrane passively at 37 °C in comparison to the statistical copolymer equivalent. 8 
This is confirmed by the observation made when DMAdiblock was incubated at 4 °C (Fig. 4), where 9 
a cytosolic distribution of DMAdiblock may be easily discerned due to the absence of the highly 10 
fluorescent puncta.  11 
According to HPLC chromatograms, the overall hydrophobicity of DMAdiblock is higher than that 12 
of DMAstat, which may be attributed to partial screening of the charges in the polycationic segment. 13 
While this difference may account for the apparent difference in cellular uptake behavior observed, 14 
differences in monomer distribution between DMAstat and DMAdiblock also need to be considered. 15 
Oda and co-workers previously explained differences in haemolytic activity between random- and 16 
block- amphiphilic copolymers by looking at differences in single-chain conformation.33 Folding 17 
in aqueous solution resulted in a conformation of the diblock in which all the charges point 18 
outwards, thus limiting hydrophobic interactions between the diblock polymer and red blood cell 19 
membranes, as compared to the statistical equivalent. Goda and co-workers previously reported 20 
that amphipathic copolymers made of polar a poly(2-methacryloyloxyethyl phosphorylcholine) 21 
(pMPC) block and a hydrophobic poly(n-butyl methacrylate) (pBMA) block had the ability to 22 
directly translocate through the cell membrane.47 In their system, the absence of the hydrophobic 23 
 26 
block resulted in the disappearance of cytosolic fluorescence, suggesting that amphiphilicity is 1 
necessary for crossing the cell membrane. Hence, we argue that for the diblock copolymer the 2 
extent of electrostatic interaction between the soluble polymer chains and the membrane is less 3 
efficient due to steric crowding of the guanidinium moieties. However, once electrostatic binding 4 
is established, insertion into the membrane and direct translocation of the polymer is more effective 5 
by virtue of a substantial hydrophobic block. On the contrary, while the statistical polymer may be 6 
able to interact more with the membrane due to the more evenly distributed guanidinium groups, 7 
they lack hydrophobic domain needed to cross and escape complexation with the membrane, 8 
explaining why the statistical copolymer is mostly present in the vesicular pathway. This is in 9 
accordance with model studies by Sommer and co-workers which showed that amphiphilicity in 10 
statistical copolymers tends to increase surface effects but inhibit translocation across lipid bilayer 11 
membrane.48 Increased interaction with the cell membrane would also account for the overall 12 
increased uptake of statistical polymers (DMAstat and HEAstat), as they possess higher affinity for 13 
the cell membrane and may thus be engulfed during endocytosis to a greater extent than their block 14 
copolymer equivalents.    15 
 27 
 1 
Figure 4. Confocal microscopic analysis of the intracellular location of DMAstat and DMAdiblock in 2 
live MDA-MB-231 cells following incubation at the indicated time and temperature Cells were 3 
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stained with Lysotracker™ Red and Hoechst 33342 to stain the lysosomes and nucleus, 1 
respectively. Co-localisation of the compounds with the lysosomes resulted in yellow spots in the 2 
overlay images. 3 
 4 
 5 
4. CONCLUSION 6 
We have prepared a range of guanidinium-rich linear polymers via RAFT polymerisation that 7 
are effective for intracellular uptake. Well-defined pGEA homopolymers (Đ ≈ 1.1) were found to 8 
enter cells predominantly via passive membrane crossing, with enhanced overall uptake by cells 9 
in comparison to polyArginine peptide analogues commonly employed in modern drug delivery. 10 
Furthermore, an optimised RAFT polymerisation approach served as a powerful tool to introduce 11 
more hydrophobic monomers in the polymeric chains, and for the first time investigate the impact 12 
of monomer distribution on the cellular uptake of guanidinium-rich copolymers. Studying the 13 
cellular uptake of well-defined copolymers (Đ < 1.2) containing either DMA or HEA as 14 
comonomer, it was found that introducing hydrophobicity could lead to enhanced cellular uptake, 15 
with the statistically distributed copolymer system based on the more hydrophobic comonomer 16 
(DMAstat > HEAstat) seemingly experiencing the highest levels of internalisation. In contrast with 17 
the homopolymers, the copolymers studied were found to be internalised to a significant extent 18 
via both endocytotic and non-endocytotic means. We highlight that the overall hydrophobicity of 19 
these soluble polymer chains is not the sole parameter dictating the extent of cellular uptake, and 20 
that the monomer distribution has a profound influence on both the level of intracellular uptake 21 
and, interestingly, the mechanism by which the copolymer is internalised. While the statistical 22 
copolymers underwent intracellular uptake to a greater extent than their segmented counterparts, 23 
 29 
confocal microscopy experiments would indicate that block copolymer microstructure is more 1 
partial towards passive membrane crossing. In all, this study represents a first step in understanding 2 
the fundamental influence of copolymer microstructure on cellular uptake. Using well-defined 3 
RAFT polymers as an alternative to polyArginine peptides provides easier-to-access materials and, 4 
through ready tuning of polymer composition and microstructure, could be used to modulate both 5 
the amount of material entering cells and their intracellular destination.  6 
 7 
 8 
 9 
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